Johnson & Johnson vs. Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?
Johnson & Johnson's latest earnings report has sent shockwaves through the healthcare industry, but beneath the surface of its strong quarterly results lies a complex puzzle that investors would do well to unravel.
The company's pharmaceutical business is firing on all cylinders, with newer medicines more than offsetting losses from older products.